Aviva PLC 10x Genomics, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $351,575 - $464,018	-2,415 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$134.22 - $202.37 $690,830 - $1.04 Million	-5,147 Reduced 68.06%	2,415 $473,000
Q1 2021 May 13, 2021	SELL	$140.25 - $196.86 $611,770 - $858,703	-4,362 Reduced 36.58%	7,562 $1.37 Million
Q4 2020 Feb 10, 2021	SELL	$126.47 - $163.7 $844,060 - $1.09 Million	-6,674 Reduced 35.89%	11,924 $1.69 Million
Q3 2020 Nov 12, 2020	SELL	$87.44 - $125.0 $732,834 - $1.05 Million	-8,381 Reduced 31.06%	18,598 $2.32 Million
Q2 2020 Aug 13, 2020	BUY	$58.39 - $89.31 $1.58 Million - $2.41 Million	26,979 New	26,979 $2.41 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.